Home » Market News » DirectorsTalk Highlights » MND Awareness Month
Oxford BioDynamics

MND Awareness Month

June is Motor Neurone Disease (MND) awareness month- MND describes a disease that affects the nerves in the brain and spinal cord that tell your muscles what to do. MND stops the messages from the nerves reaching those muscles causing the muscles to stiffen and weaken.

MND can affect up to 1 in 300 people and MND affects up to 5000 adults in the UK at any one time.

Oxford Biodynamics PLC (LON:OBD) was spun out from Oxford University in June 2007 with the aim of translating fundamental scientific advances into a commercialised platform technology and a new generation of biomarkers for cancer and other diseases. OBD has been granted a substantial funding award from Innovate UK to develop and validate diagnostic, prognostic and predictive EpiSwitch™ biomarkers for ALS.

To read the full news article please click here

Receive our exclusive interviews – Enter your email to stay up to date.

Disclaimer: Statements in this article should not be considered investment advice, which is best sought directly from a qualified professional.